Study Evaluating the Safety and Efficacy of Piperacillin/Tazobactam and Ampicillin/Sulbactam in Patients With Diabetic Foot Infections
Clinical trial NCT00044746 · COMPLETED
Trial details
- NCT number
- NCT00044746
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2000-10-01
- Primary completion
- 2003-01-01
- Enrollment
- 314
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.